Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Combination Treatment With Methotrexate and Cyclosporine in Early Rheumatoid Arthritis

Next Previous
Trial Profile

Combination Treatment With Methotrexate and Cyclosporine in Early Rheumatoid Arthritis

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Jan 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ciclosporin (Primary) ; Betamethasone; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms CIMESTRA

    • Most Recent Events

    • 09 Nov 2021 Results assessing plasma levels of CXCL13, and its ability to predict radiographic joint destruction, presented at the ACR Convergence 2021.
    • 06 Jun 2020 Results assessing vitamin D trajectories from time of diagnosis through 10 years follow-up in early diagnosed RA patients presented at the 21st Annual Congress of the European League Against Rheumatism
    • 01 Jul 2018 Results of post-hoc analysis from CIMESTRA and OPERA trials published in the Scandinavian Journal of Rheumatology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top